Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    India
    Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis
    Tuberculosis (TB)
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    India
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    Recent deal offering controlled generics access in limited countries does not go far enough.
    Tuberculosis (TB)
    Access to medicines
    Stay up to date
    © Doctors Without Borders
    Privacy Policy